References
- Periti P. Attualità delle cefalosporine nella chemioterapia antimicrobica. Farm Ter 2000; XVII (Suppl), in corso di stampa.
- Periti P, Nicoletti P. Classification of betalactam antibiotics according to their pharmacodynamics. J Chemother 1999; 11 (5): 323–330.
- Norrby SR. Cost-effective prophylaxis of surgical infections. Pharmacoeconomics 1996; 10 (2): 129–140.
- Davis R, Bryson HM. Ceftriaxone. A pharmacoeconomic evaluation of its use in the treatment of serious infections. Pharmacoeconomics 1994; 6 (3): 249–269.
- L’Informatore farmaceutico. 60a Edizione. OEMF SpA, Milano, 2000.
- Mangram AJ, Horan TC, Pearson ML, Silver LC, Jarvis WR, the Hospital Infection Control Practices Advisory Committee. Guideline for prevention of surgical site infection, 1999. Infect Control Hosp Epidemiol 1999; 20 (4): 247–280.
- Horan TC, Gaynes RP, Martone WJ, Jarvis WR, Emori TG. CDC definitions of nosocomial surgical site infections, 1992: a modification of CDC definitions of surgical wound infections. Infect Control Hosp Epidemiol 1992; 13 (10): 606–608.
- Center for Disease Control and Prevention. National Center for Health Statistics. “Vital and Health Statistics, Detailed Diagnoses and Procedures, National Hospital Discharge Survey, 1994”. Vol 127. DHHS Publication, Hyattsville - Maryland 1997.
- Martone WJ, Jarvis WR, Culver DH, Haley RW. Incidence and nature of endemic and epidemic nosocomial infectious. In: “Hospital Infections” (Bennett JV, Brachman PS, Eds), 3rd ed. Little, Brown and Co, Boston 1992: 577–596. et al., 1980
- Boyce JM, Potter-Byone G, Dziobek L. Hospital reimbursement patterns among patients with surgical wound infections following open heart surgery. Infect Control Hosp Epidemiol 1990; 11 (2): 89–93.
- Vegas AA, Jodra VM, Garcia ML. Nosocomial infection in surgery wards: a controlled study of increased durantion of hospital stays and direct cost of hospitalization. Eur J Epidemiol 1993; 9 (5): 504–510.
- Albers BA, Patka P, Haarman HJ, Kostense PJ. Cost effectiveness of preventive antibiotic administration for lowering risk of infection by 0.25%. [German]. Unfallchirurg 1994; 97 (12): 625–628.
- Poulsen KB, Bremmelgaard A, Sorensen AI, Raahave D, Petersen JV. Estimated costs of postoperative wound infections. A case-control study of marginal hospital and social security costs. Epidemiol Infect 1994; 113 (2): 283–295.
- Burke JF. The effective period of preventive antibiotic action in experimental incisions and dermal lesions. Surgery 1961; 50 (1): 161–168.
- Hill C, Flamant R, Mazas F, Evrard J. Prophylactic cefazolin versus placebo in total hip replacement. Lancet 1981; April 11: 795–797.
- Nichols RL. Use of prophylactic antibiotics in surgical practice. Am J Med 1981; 70: 686–692.
- Periti P, Mazzei T. Principles of antimicrobial chemoprophylaxis in surgery. Chemioterapia 1987; VI (3): 196–201.
- Classen DC, Evans RS, Pestotnik SL, Horn DS, Menlove RL, Burke JP. The timing of prophylactic administration of antibiotics and the risk of surgical-wound infection. N Engl J Med 1992; 326 (5): 281–286.
- Sanderson PJ. Antimicrobial prophylaxis in surgery: microbiological factors. J Antimicrob Chemother 1993; 31 (Suppl B): 1–9.
- Martin C. Antimicrobial prophylaxis in surgery: general concepts and clinical guidelines. Infect Control Hosp Epidemiol 1994; 15 (7): 463–471.
- Leaper DJ. Use of antibiotic prophylaxis in clean non-implant wounds – Leading article. J Antimicrob Chemother 1998; 41: 501–504.
- Periti P, Stringa G, Mini E, and the Italian Study Group for Antimicrobial Prophylaxis in Orthopedic Surgery. Comparative multicenter trial of teicoplanin versus cefazolin for antimicrobial prophylaxis in prosthetic joint implant surgery. Eur J Clin Microbiol Infect Dis 1999; 18: 113–119.
- Page CP, Bohnen JM, Fletcher JR, McManus AT, Solomkin JS, Wittmann DH. Antimicrobial prophylaxis for surgical wounds. Guidelines for clinical care. Arch Surg 1993; 128 (1): 79–88.
- Nichols RL, Holmes JW. Prophylaxis in bowel surgery. Curr Clin Top Infect Dis 1995; 15: 76–96.